← Back to all clusters

Cluster 603

5 diseases · 10 shared-gene connections
5 Diseases
5 Unique genes
0.367 Avg. similarity score
Cholesteatoma Most-connected disease (4 links)
Log in to save this analysis

Save This Analysis

Disease Searched: Intellectual disability with autism spectrum disorder Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
TBL1XR1 5 / 5 Cholesteatoma, Intellectual developmental disorder, autosomal dominant 41, Intellectual disability with autism spectrum disorder, Mental retardation, autosomal dominant 41 and 1 more
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Coronavirus disease - COVID-19 KEGG 2 / 238 20.2× 3.76e-3 2.99e-2 ✓ sig.
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) Reactome 1 / 10 240× 4.16e-3 3.21e-2 ✓ sig.
Interleukin-2 signaling Reactome 1 / 12 200× 4.99e-3 3.64e-2 ✓ sig.
RORA activates gene expression Reactome 1 / 18 133× 7.47e-3 4.73e-2 ✓ sig.
Regulation of lipid metabolism by PPARalpha Reactome 1 / 20 120× 8.30e-3 5.06e-2
Common Pathway of Fibrin Clot Formation Reactome 1 / 22 109× 9.13e-3 5.37e-2
Interleukin receptor SHC signaling Reactome 1 / 27 89.0× 1.12e-2 6.09e-2
Notch-HLH transcription pathway Reactome 1 / 28 85.8× 1.16e-2 6.22e-2
Circadian Clock Reactome 1 / 28 85.8× 1.16e-2 6.22e-2
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux Reactome 1 / 37 64.9× 1.53e-2 7.35e-2
Allograft rejection KEGG 1 / 39 61.6× 1.61e-2 7.58e-2
Activation of gene expression by SREBF (SREBP) Reactome 1 / 42 57.2× 1.74e-2 7.88e-2
Type I diabetes mellitus KEGG 1 / 44 54.6× 1.82e-2 8.12e-2
Graft-versus-host disease KEGG 1 / 45 53.4× 1.86e-2 8.21e-2
Intestinal immune network for IgA production KEGG 1 / 50 48.0× 2.06e-2 8.75e-2

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
response to tacrolimus GO:1901327 1 / 2 1,869× 5.35e-4 9.88e-3 ✓ sig.
regulation of CD4-positive, alpha-beta T cell proliferation GO:2000561 1 / 2 1,869× 5.35e-4 9.88e-3 ✓ sig.
leukocyte activation involved in immune response GO:0002366 1 / 3 1,246× 8.03e-4 1.28e-2 ✓ sig.
regulation of T cell homeostatic proliferation GO:0046013 1 / 3 1,246× 8.03e-4 1.28e-2 ✓ sig.
positive regulation of plasma cell differentiation GO:1900100 1 / 4 934× 1.07e-3 1.51e-2 ✓ sig.
positive regulation of tissue remodeling GO:0034105 1 / 6 623× 1.60e-3 1.88e-2 ✓ sig.
negative regulation of lymphocyte proliferation GO:0050672 1 / 7 534× 1.87e-3 2.05e-2 ✓ sig.
positive regulation of lymphocyte differentiation GO:0045621 1 / 8 467× 2.14e-3 2.19e-2 ✓ sig.
regulation of triglyceride metabolic process GO:0090207 1 / 8 467× 2.14e-3 2.19e-2 ✓ sig.
blood coagulation, fibrin clot formation GO:0072378 1 / 9 415× 2.41e-3 2.32e-2 ✓ sig.
negative regulation of T-helper 17 cell differentiation GO:2000320 1 / 9 415× 2.41e-3 2.32e-2 ✓ sig.
fat pad development GO:0060613 1 / 10 374× 2.67e-3 2.46e-2 ✓ sig.
activated T cell proliferation GO:0050798 1 / 10 374× 2.67e-3 2.46e-2 ✓ sig.
negative regulation of B cell apoptotic process GO:0002903 1 / 11 340× 2.94e-3 2.58e-2 ✓ sig.
positive regulation of isotype switching to IgG isotypes GO:0048304 1 / 11 340× 2.94e-3 2.58e-2 ✓ sig.

Pairs within this cluster, by significance